Pfizer

Selected news for the company - Pfizer, collected since 10/2017. Recent stories appear in Kaiser Health News and Washington Examiner. This company shares news with COVID-19, COVID-19 Vaccine, Coronavirus, Moderna, AstraZeneca and hundreds of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
7/21/2021 A Guiding Light for the Research Safe Harbor and “Research Tools”? natlawreview.com A Guiding Light for the Research Safe Harbor and “Research Tools”? Allele v. Pfizer – The Basics. On April 23, 2021 Pfizer , Inc., BioNTechSE, and BioNTech US, Inc. (“Pfizer and BioNTech”) filed a joint reply supporting of their previously filed motion to dismiss a patent infringement complaint filed by Allele Biotechnology and Pharmaceuticals, Inc. (“Allele”) in the Southern District of California. The patent at the center of ...
7/21/2021 Type 2 Diabetes Pipeline Holds a Potential Future in Treatment Scenario. Globe Newswire ... the key takeaways from the Type 2 Diabetes Pipeline ReportMajor companies such as AgeX Therapeutics, CarmotTherapeutics, Novo Nordisk, Jiangsu Hengrui Medicine, Ionis Pharmaceuticals, Eli Lilly and Company, Oramed Pharmaceuticals, AstraZeneca, Melior Pharmaceuticals, Adocia, Pfizer , Genexine, Inc., OPKO Health, Inc., VitNovo, Inc., Sciwind Biosciences, Caelus Health, SCOHIA PHARMA, Aerami Therapeutics, Viking Therapeutics, VTV Therapeutics, AptamiR Therapeutics, Avolynt, Inc., Suzhou Yabao Pharmaceutical, CONJUCHEM, LLC., Hua Medicine, REMD Biotherapeutics, Novmeta Pharma, Afimmune ...
7/21/2021 Vedanta raises $68M, reveals setback to Bristol Myers alliance FierceBiotech ... data in Clostridioides difficile infection (CDI), Vedanta has put together a syndicate of investors to support plans for further development of its pipeline.The $68 million includes a previously disclosed $25 million investment from Pfizer . Magnetar Capital led the series D with the support of new and existing investors including Verition Fund Management, Fosun Health Capital and PureTech Health, which co-founded Vedanta and owned almost half the biotech as ...
7/21/2021 FDA approves another pneumococcal vaccine that's effective in older adults McKnight's Long Term Care News ... 15 strains of bacteria that can cause pneumonia and other acute respiratory disease, and has shown evidence of efficacy in older adults. The FDA’s approval Friday comes one month after the agency greenlit Pfizer ’s pneumonia shot Prevnar 20. Vaxneuvance was not compared to the Prevnar 20 shot, which adds protection against seven more microorganisms than Pfizer ’s widely used Prevnar 13. However, the new vaccine did prompt a ...
7/21/2021 Hy-Vee to offer walk-in COVID vaccine clinics at 2021 Iowa State Fair Des Moines Register ... been at the forefront of COVID vaccination since it rolled out in December, so this made sense for us," Hy-Vee spokesperson Christina Gayman said.The clinic will offer vaccines from Johnson & Johnson and Pfizer . The Johnson & Johnson vaccine only requires one dose to reach full effectiveness, but is only approved for people 18 and older. The Pfizer vaccines requires two doses for full effectiveness, with the second dose coming ...
7/21/2021 New study suggests J&J recipients should get booster shot to protect against Delta variant The Week ... give was not that people shouldn't get the J&J vaccine, but we hope that in the future, it will be boosted with either one dose of J&J or a booster with [the Pfizer and Moderna COVID-19 vaccines]," Nathaniel Landau, a virologist at New York University's Grossman School of Medicine who led the study, told the Times . The study, which has not been peer reviewed, involvded Landau and ...
7/21/2021 Johnson & Johnson expects $2.5 billion in global sales from Covid vaccine this year CNBC ... in global sales from Covid vaccine this yearWHO chief warns that the world is going into the 'early stages of another wave'Dr. Vin Gupta encourages J&J vaccine recipients to get a Pfizer or Moderna booster'If anybody is lying here senator, it is you,' Fauci tells Sen. Paul in heated exchange at Senate hearingJ&J's pharmaceutical business, which developed the single-shot Covid vaccine, generated $12.59 ...
7/21/2021 Man Getting Bell's Palsy After Both Pfizer COVID Vaccines May Be 'Coincidence' Newsweek A man who received the Pfizer COVID vaccine has experienced facial nerve issues after each of his two vaccine doses, in what is thought to be the first reported case of its type.However, doctors could not determine whether the nerve issues, known as Bell's palsy, were caused by the vaccine doses.And one medical statistician not involved in the case study has highlighted the possibility that both of the ...
7/21/2021 When will COVID-19 vaccines be fully approved—and does it matter if they are? sciencemag.org ... reason is that less than half of the U.S. population is fully vaccinated. Some scientists and physicians worry vaccine hesitancy is fueled by the fact that shots available in the United States—made by Pfizer -BioNTech, Moderna, and Johnson & Johnson (J&J)—have been authorized on an emergency basis but have yet to be fully approved. Antivaccine activists, talk show hosts, and far-right politicians have made the vaccines’ ...
7/21/2021 11 Countries that are Planning or Have Decided to Mix the Doses of the Covid-19 Vaccine, Including Indonesia newsy-today.com ... 19 vaccine to increasing immunity. The mix varies from country to country. For example, in Vietnam, people who have been injected with the AstraZeneca vaccine at the first dose are allowed to get the Pfizer vaccine at the second dose. The World Health Organization (WHO) warns against mixing and matching Covid-19 vaccines from different manufacturers. “It’s a dangerous trend here,” World Health Organization chief scientist Soumya Swaminathan ...
7/20/2021 WATCH: Perspectives on the Pandemic #16 off-guardian.org Dr Mike Yeadon, formerly a Vice President and Chief Science Officer at Pfizer , believes the big experiment is well underway, and that the hypothesis it seeks to prove is as bold as it is terrible. A cogent and clear thinker who has been attacked in proportion to his qualifications, Dr. Yeadon, at great personal risk, issues a chilling warning, not just about the grave dangers surrounding the injections, but about ...
7/20/2021 COVID cases on the rise: Vaccinated people test positive | 13newsnow.com 13newsnow.com ... COVID19 can make someone, and Hudson has two elderly parents she’s been concerned about protecting.That’s why both jumped at the opportunity to get vaccinated when the opportunity arose. Perez received her Pfizer shots in December and Hudson was fully vaccinated by January.Hudson says being vaccinated caused her to let her guard down and return to “normal” behaviors.RELATED: 'Lambda' variant detected as Houston COVID cases ...
7/20/2021 An Urgent Message to The World theburningplatform.com The interview YouTube doesn’t want you to see: Dr. Mike Yeadon, formerly a Vice President and Chief Science Officer at Pfizer , believes the big experiment is well under way, and that the hypothesis it seeks to prove is as bold as it is terrible. A cogent and clear thinker who has been attacked in proportion to his qualifications, Dr. Yeadon, at great personal risk, issues a chilling warning, not ...
7/20/2021 Antidiabetic Drug Market 2020 UPDATE | AstraZeneca plc, Biocon Restricted, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Firm curiousdesk.com ... portfolio of key distributors AstraZeneca plc, Biocon Restricted, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Firm, Eli Lilly and Firm, Halozyme Therapeutics, Inc., Johnson & Johnson, Merck KGaA, Novo Nordisk A/S, Oramed Prescription drugs Inc., Pfizer Inc., Takeda Pharmaceutical Firm Ltd, Tonghua Dongbao Pharmaceutical Co., Ltd., Wockhardt Restricted, and sanofi-aventis U.S. LLC. Click on Right here For Our Free Complimentary Pattern Report: A Temporary Introduction of the analysis report, TOC ...
7/20/2021 Over The Counter (OTC) Drugs Market 2021-27 surge promising growth with Bayer, GlaxoSmithKline, Johnson & Johnson, Pfizer, Sanofi PRSync Over The Counter (OTC) Drugs Market 2021-27 surge promising growth with Bayer, GlaxoSmithKline, Johnson & Johnson, Pfizer, Sanofi [reportsandmarkets] Global Over The Counter (OTC) Drugs Market Size, Status and Forecast 2021-2027 The latest Over The Counter (OTC) Drugs Market report published by ReportsandMarkets offers a competency-based analysis and global market estimate, developed using evaluable methods, to provide a clear view of current and expected growth patterns. The report also contains ...
7/20/2021 Cancer Therapeutics Market to Reach US$ 248.7 billion, Globally, by 2027 at 7.8% CAGR ‚Äì Decisive Markets Insights icrowdnewswire.com ... avail Sample Copy of report, visit [email protected] https://www.decisivemarketsinsights.com/cancer-therapeutics-market/38852421/request-sample Cancer Therapeutics Market Key Players- Companies reported in this report are: F. Hoffmann-La Roche, Novartis AG, Johnson and Johnson, Pfizer Inc., Sanofi SA, Merck & Co., Inc, GlaxoSmithKline plc, Eli Lilly GLOBAL CANCER THERAPEUTICS MARKET, BY TYPES Prostate Cancer Blood Cancer Lung Cancer Skin Cancer Gastrointestinal Cancer Breast Cancer Others GLOBAL CANCER THERAPEUTICS MARKET, BY THERAPY ...
7/20/2021 Ukraine Pharmaceutical and Healthcare Industry Report 2021 – ResearchAndMarkets.com | Financial Buzz financialbuzz.com ... Analysis 2021” report has been added to ResearchAndMarkets.com’s offering.Ukraine is still struggling to control the COVID-19 pandemic, but with approval of the Johnson & Johnson coronavirus vaccine along with vaccines from Pfizer and AstraZeneca, it is expected that the increasing vaccination of its population should make a difference and control the spread of the outbreak.The pharmaceutical industry in Ukraine is amongst the ten biggest pharmaceutical industries ...
7/20/2021 Pulmonary Arterial Hypertension Treatment Market Trends, Market Size Share And Structure 2021 heraldkeeper.com ... including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Actelion Pharmaceuticals, Ltd., Gilead Sciences, Inc., United Therapeutics Corporation, Bayer HealthCare, Pfizer , Inc., Novartis International AG and GlaxoSmithKline plc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments. The Pulmonary Arterial Hypertension Treatment Market is expected to ...
7/20/2021 Harbor BioMed Appoints Yingying Chen, PhD, Chief Financial Officer bollyinside.com ... including UBS, Royal Bank of Scotland/ABN AMRO Bank, and Deutsche Bank AG, where she served clients in the healthcare sector. In her earlier career, she had also worked as a Research Scientist at Pfizer ’s global R&D center. SOURCE Harbour BioMed About Harbour BioMed Harbour BioMed (HKEX: 02142) is a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on oncology and ...
7/20/2021 NIH head says full Pfizer vaccine approval could come this summer McKnight's Long Term Care News Waiting for full federal approval of Pfizer’s COVID-19 vaccine is no reason to delay protection, the director of the National Institutes of Health said Monday, but those still holding out for the end of the emergency authorization period might have only weeks to go. The Food and Drug Administration could grant full approval of the Pfizer BioNTech vaccine “by the end of the summer,” Francis Collins, M.D ...